✦ LIBER ✦

Clinical observation of treatment with Yiqi Jianpi decoction combined with FOLFOX4 for the postoperation patients of colorectal cancer

✍ Scribed by Cao, Bo; Den, Wenling

Book ID: 118793431
Publisher: Springer
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 11
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-012-1017-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical observation of Fufangchangtai d

Clinical observation of Fufangchangtai decoction combined with FOLFOX4 regimen for postoperative colorectal cancers

✍ Lingchang Li; Mingzhi Fang; Xiaoning Wang; Jiege Huo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 196 KB

Treatment with Yiqi Bushen Koufuye Combi

Treatment with Yiqi Bushen Koufuye Combined with Chemotherapy for Preventing Postoperative Metastasis of Stomach Cancer — A Clinical Observation of 28 Cases

✍ Yun-xia LIU; Shen-jun JIANG; Tang-hong KUANG; Yong-wei YAO; Jie-wen YANG; Yi-qin 📂 Article 📅 2009 🏛 Elsevier ⚖ 180 KB

The clinical observation of three-dimens

The clinical observation of three-dimensional conformal radiotherapy combined with FOLFOX chemotherapy for rectal cancer of postoperative local recurrence

✍ Zhou, Yeqin; Liu, Mi; Ma, Daiyuan; Ren, Tao; Ma, Xiaojie; Li, Xianfu; Tan, Bangx 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 295 KB

PCN26 A COST-EFFECTIVENESS ANALYSIS OF X

PCN26 A COST-EFFECTIVENESS ANALYSIS OF XELOX AND FOLFOX-4 COMBINED WITH OR WITHOUT BEVACIZUMAB FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN SPAIN

✍ J Darba; G Restovic; A Ramírez de Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

First clinical experience of orally acti

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

✍ Maria Giulia Zampino; Elena Magni; Cristian Massacesi; Alberto Zaniboni; Angelo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND. Gefitinib, an orally active inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, combined with chemotherapy, has shown efficacy as second‐line treatment for advanced colorectal cancer (CRC). Gefitinib combined with FOLFOX6 (oxaliplatin plus folinic acid

Anti-EGFR (cetuximab) combined with irin

Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)

✍ S. Abdelwahab, A. Azmy, H. Abdel-aziz, H. Salim, A. Mahmoud 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 219 KB